1354489-36-3

Upstream product

• 17324-04-8 3-methyl-naphthalen-2-ol 
• 1322036-27-0 1-chloro-3-methyl-naphthalen-2-ol 
• 1354490-94-0 trifluoromethanesulfonic acid 1-chloro-3-methylnaphthalen-2-yl ester 
• 1354490-95-1 1-chloro-3-methyl-2-vinylnaphthalene 
• 1354490-96-2 (S)-1-(1-chloro-3-methylnaphthalen-2-yl)ethane-1,2-diol 
• 1354490-97-3 (S)-2-(1-chloro-3-methylnaphthalen-2-yl)-2-hydroxyethyl pivalate 
• 1354490-98-4 (S)-2-tert-butoxy-2-(1-chloro-3-methylnaphthalen-2-yl)ethyl pivalate 
• 1354491-03-4 (S)-2-tert-butoxy-2-(1-chloro-3-methylnaphthalen-2-yl)ethanol 
• 1354491-04-5 (S)-2-tert-butoxy-2-(1-chloro-3-methylnaphthalen-2-yl)acetic acid 
• 1354491-05-6 (S)-ethyl 2-tert-butoxy-2-(1-chloro-3-methylnaphthalen-2-yl)acetate 
• 1354491-06-7 (S)-ethyl 2-tert-butoxy-2-(1-cyclohexenyl-3-methylnaphthalen-2-yl)acetate 

Relevant academic research and scientific papers

NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula (I).